WIRE — Trump's proposed tariff plan gives generic drugmakers a two-year window before duties kick in. Here's how it could impact Indian pharma companies from Sun Pharma to Dr. Reddy's.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.